First Business Financial Services Inc. Has $458,000 Position in Monsanto Co. (MON)
First Business Financial Services Inc. reduced its position in shares of Monsanto Co. (NYSE:MON) by 5.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,426 shares of the company’s stock after selling 248 shares during the period. Monsanto accounts for approximately 0.1% of First Business Financial Services Inc.’s portfolio, making the stock its 27th largest position. First Business Financial Services Inc.’s holdings in Monsanto were worth $458,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Howard Hughes Medical Institute bought a new position in Monsanto during the first quarter valued at $110,000. Bartlett & Co. LLC raised its position in Monsanto by 10.6% in the second quarter. Bartlett & Co. LLC now owns 1,402 shares of the company’s stock valued at $145,000 after buying an additional 134 shares during the period. Carnick & Kubik LLC bought a new position in Monsanto during the first quarter valued at $130,000. Quadrant Capital Group LLC raised its position in Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock valued at $184,000 after buying an additional 16 shares during the period. Finally, Palladium Partners LLC bought a new position in Monsanto during the second quarter valued at $205,000. 79.02% of the stock is currently owned by institutional investors and hedge funds.
Shares of Monsanto Co. (NYSE:MON) traded up 1.27% during midday trading on Wednesday, hitting $102.90. The company had a trading volume of 2,937,248 shares. The firm’s 50 day moving average is $104.97 and its 200 day moving average is $101.31. The company has a market capitalization of $45.03 billion, a P/E ratio of 45.29 and a beta of 1.19. Monsanto Co. has a 52 week low of $83.73 and a 52 week high of $114.26.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. The business had revenue of $2.56 billion for the quarter, compared to the consensus estimate of $2.38 billion. During the same quarter last year, the business posted ($0.19) earnings per share. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Equities research analysts anticipate that Monsanto Co. will post $4.46 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 2.11%. Monsanto’s payout ratio is 89.26%.
Several research analysts have weighed in on MON shares. S&P Equity Research reaffirmed a “positive” rating on shares of Monsanto in a research report on Thursday, September 15th. Vetr upgraded Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 target price for the company in a research note on Monday, June 27th. Piper Jaffray Cos. reiterated an “overweight” rating and set a $118.00 target price on shares of Monsanto in a research note on Sunday, August 21st. Citigroup Inc. reiterated a “neutral” rating and set a $112.00 target price on shares of Monsanto in a research note on Monday, July 18th. Finally, Goldman Sachs Group Inc. set a $92.00 target price on Monsanto and gave the stock a “sell” rating in a research note on Monday, June 27th. Two analysts have rated the stock with a sell rating, nine have given a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $114.21.
In other news, COO Brett D. Begemann sold 27,980 shares of Monsanto stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now owns 102,480 shares in the company, valued at $10,618,977.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Michael K. Stern sold 12,797 shares of Monsanto stock in a transaction dated Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the transaction, the chief executive officer now owns 21,583 shares in the company, valued at approximately $2,196,501.91. The disclosure for this sale can be found here. Company insiders own 0.88% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.